What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Harvey A. Risch spends much of his time researching Internal medicine, Odds ratio, Cancer, Ovarian cancer and Case-control study.
He has included themes like Gastroenterology, Endocrinology and Oncology in his Internal medicine study.
The concepts of his Oncology study are interwoven with issues in Germline mutation, Relative risk, Breast cancer, Endometrial cancer and Genetic testing.
Harvey A. Risch combines subjects such as Genome-wide association study, Epidemiology, Incidence, Pancreatic cancer and Confidence interval with his study of Odds ratio.
His research integrates issues of Cancer research, Gynecology, Serous fluid and Ovary in his study of Ovarian cancer.
His Case-control study research focuses on Surgery and how it relates to Socioeconomic status, Pediatrics and Pooled analysis.
His most cited work include:
- Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies (2742 citations)
- Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (951 citations)
- Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer (838 citations)
What are the main themes of his work throughout his whole career to date?
Harvey A. Risch mostly deals with Internal medicine, Oncology, Cancer, Ovarian cancer and Odds ratio.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Genome-wide association study.
His studies deal with areas such as Carcinoma, Hazard ratio, Breast cancer, Single-nucleotide polymorphism and Endometrial cancer as well as Oncology.
His research in Cancer is mostly concerned with Prostate cancer.
His study looks at the relationship between Ovarian cancer and fields such as Gynecology, as well as how they intersect with chemical problems.
His study focuses on the intersection of Odds ratio and fields such as Confidence interval with connections in the field of Logistic regression.
He most often published in these fields:
- Internal medicine (59.63%)
- Oncology (37.50%)
- Cancer (30.74%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (59.63%)
- Oncology (37.50%)
- Genome-wide association study (22.34%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Oncology, Genome-wide association study, Pancreatic cancer and Genetic association.
He regularly links together related areas like Mendelian Randomization Analysis in his Internal medicine studies.
The various areas that Harvey A. Risch examines in his Oncology study include Quantitative trait locus, Breast cancer, Endometrial cancer and Hazard ratio.
His Genome-wide association study study incorporates themes from Transferrin, Cancer research and Ferritin.
Harvey A. Risch has researched Ovarian cancer in several fields, including Odds ratio, Logistic regression and Depression.
The study incorporates disciplines such as Absolute risk reduction, Barrett's esophagus and Risk factor in addition to Single-nucleotide polymorphism.
Between 2019 and 2021, his most popular works were:
- Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis. (37 citations)
- Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. (28 citations)
- Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. (13 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary areas of study are Internal medicine, Oncology, Genome-wide association study, Genetic association and Pandemic.
Harvey A. Risch conducts interdisciplinary study in the fields of Internal medicine and Hydroxychloroquine through his research.
His Oncology research is multidisciplinary, incorporating perspectives in Cancer, Breast cancer, Endometrial cancer, Biomarker and Cancer syndrome.
His Cancer research incorporates elements of Penetrance, Germline mutation, Exome and Allele frequency.
His Genome-wide association study study integrates concerns from other disciplines, such as Ovarian cancer, Genetic correlation and Pancreatic cancer.
His KRAS study combines topics from a wide range of disciplines, such as Odds ratio and Single-nucleotide polymorphism.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
